Home / Developing Long-Acting Drug Formulation? Be on the Safe Side

Developing Long-Acting Drug Formulation? Be on the Safe Side

March 26, 2021

Join us to learn how to overcome the drug development challenges associated with the scale-up of your sterile microsphere drug pipeline in your lab and production facilities

Did you know that 50% of the chronic disease patients do not comply with their drug therapy? This has been recognised by WHO (World Health Organisation) to be a major global health problem of ‘striking magnitude’, resulting in poor health outcomes and increased health care costs.

Microsphere depot injections address huge challenges in chronic disease treatment and offer blockbuster potential for pharmaceutical companies. Register today to this webinar to learn more about this exciting area of the pharmaceutical market.

Microsphere or microparticle depot injections are complex drug formulations that combine an Active Pharmaceutical Ingredient (API) with a bioresorbable polymer such as PLGA. Microsphere-based injections enable the sustained release of APIs over prolonged periods of time, varying from weeks up to several months.

Join our PSL experts as we talk through the key considerations in early development, scale-up, downstream processing for microsphere-based drug products. We will also introduce you to the most advanced manufacturing innovation as we launch the latest generation of our MicroSphere Refiner technology (MSR).

Whether you are new to the field of microspheres or currently developing a long-acting injectable product, you will benefit from our PSL expertise and learn how you can streamline your microsphere drug product development.

DATE

30 March 2021 (Tuesday)

TIME

3:00pm UTC (CET +1)

LOCATION

Online Webinar
Register Now

SPEAKERS

Pierre Landais
Director, Global Business Development

Christian Parker
Director of Engineering

This Webinar Will Begin In:
0
0
0
0
Days
0
0
Hrs
0
0
Min
0
0
Sec